The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS10384
Drug delivery systems known as wearable injectors attach to the body and automatically administer patients’ prescribed doses at the right moment. Wearable injectors, in contrast to insulin pumps, is a one-time use devices that are comfortably worn on the body while the medication is subcutaneously injected over a pre-programmed period of seconds or hours. They are taken out of the body and conveniently disposed after the entire dose has been injected. The concept of patient centricity and a greater emphasis on human factors in drug delivery design have encouraged the development of such devices.
Market Trends and Drivers
A growing emphasis on the use of biologics and monoclonal antibodies (mAbs) to treat diseases such as rheumatoid arthritis, cardiovascular disease, and cancer will provide significant growth opportunities for wearable injectors, as these drugs must be administered parenterally (intravenous, subcutaneous, or intramuscular delivery). According to PhRMA (Pharmaceutical Research and Manufacturers of America), 907 biologics were in development in 2013; the number of biologic drugs in development is continuing to grow exponentially, with over 2,700 remedies in development as of mid-2017, more than tripling the 907 in development in 2013. mAb-based biotherapies account for half of the top 100 drugs and are expected to continue to dominate the pharmaceutical market.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10384
Major Players in the Global Wearable Injectors Market
The key players in the market are Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care (US), Sonceboz (Switzerland), Noble (US), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (UK), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (US) among others.
COVID-19 Impact
The COVID-19 pandemic’s uncertainty has influenced demand for various therapies and wearable drug delivery devices. To prevent the spread of the infection and to keep high-risk patients from becoming infected, healthcare systems around the world delayed treatments for diseases such as cancer. The risks for patients receiving care increased as the pandemic began. During the pandemic, hospitals, where the majority of patients receive treatment, also became high-risk environments. To address these challenges and provide effective care to patients suffering from various diseases, a shift from hospital-based care to home-based care has occurred.
Due to the COVID-19 pandemic, NHS England in the United Kingdom implemented a programme that allows cancer patients to receive convenient, non-hospital-based treatments. During this pandemic, the use of wearable injectors for the delivery of oncology drugs and other maintenance therapies that are currently in clinical trials has gained traction.
Market Segments
By Type
- On-Body
- Off-Body
By Technology
- Spring-based
- Motor Driven
- Rotary Pump
- Expanding Battery
By Application
- Diabetes
- Oncology
- Cardiovascular Disease
- Others
By End-use
- Clinics
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Others
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS10384
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/